A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
Clinical trial NCT07680166 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680166
- Sponsor
- Xentria, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2029-10-31
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.